```yaml
---
title: Artifact 12A: mTOR and Autophagy - MS-Supportive Weekly Meal Plan (Plan A: Foundation)
date: June 4, 2025, 3:59 PM BST
author: Your Name
geometry: margin=1in
toc: false
---
```

# Artifact 12A: mTOR and Autophagy - MS-Supportive Weekly Meal Plan (Plan A: Foundation)

## Introduction

This is **Artifact 12A: mTOR and Autophagy (Plan A: Foundation)**, exploring the roles of mechanistic target of rapamycin (mTOR) and autophagy in a 7-day meal plan (June 25–July 1, 2025) tailored for a 54-year-old male with multiple sclerosis (MS) weighing 71.8 kg, focusing on **mitochondrial health** to support energy, mobility, cognitive function, and symptom management. Plan A, the foundation plan, delivers ~115 g/day protein, ~9.6–12.2 g/day leucine, and ~249.14–480.78 mg/day flavonoids, with **circadian alignment** to optimize **ADP/ATP cycles**, **NAD/NADH** and **FAD/FADH2 cycles**, **mitophagy**, **sirtuins**, **telomeres**, **mTOR activity**, and **sleep regulation**, while maintaining **low-histamine**, **low-oxalate**, and **low-antinutrient** preferences, and addressing user needs (eggs for alertness/sleep, tinned fish for gut health, no apples/cocoa due to neuropathy, minimal chicken). This document details how Plan A balances mTOR activation (via leucine/protein) and autophagy (via fasting) to support neural repair, reduce inflammation, and manage MS symptoms (e.g., fatigue, spasticity, cognition). **Plan B** has adjusted mTOR/autophagy strategies (see **Artifact_12B_mTORAutophagy_PlanB.md**). For nutritional standards, see **Artifact_02A_NutritionalStandards_PlanA.md**; for routine, see **Artifact_03A_DailyRoutine_PlanA.md**; for menu, see **Artifact_04A_DetailedMenu_PlanA.md**; for shopping, see **Artifact_06A_ShoppingList_PlanA.md**; for tracking, see **Artifact_11A_TrackingTools_PlanA.md**; for leucine timing, see **Artifact_08A_LeucineTiming_PlanA.md**; for circadian health, see **Artifact_17A_MelatoninCircadian_PlanA.md**. Use Markdown Reader (https://markdownreader.github.io/) to view ([Physiother Res Int., 2024](https://onlinelibrary.wiley.com/doi/10.1002/pri.2087)).

## mTOR and Autophagy in MS

### mTOR Pathway
- **Role**: The mTOR pathway regulates protein synthesis, cell growth, and neural plasticity, critical for the brain-muscle connection in MS. Leucine-rich meals activate mTOR, promoting muscle maintenance and neural repair, which can reduce spasticity and fatigue ([Muscle Nerve, 2018](https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6039135/)).
- **Plan A Strategy**:
  - **Leucine Intake**: ~9.6–12.2 g/day (~4.8–6.1 g/meal) via eggs (~2.0–2.4 g/4 eggs, all 14 meals), tinned fish (~1.8–2.0 g/100 g, 10 meals), turkey/chicken (~2.0–2.2 g/100 g, 5 meals), tofu (~1.5 g/100 g, 7 meals), and liver (~1.0–1.2 g/50 g, 1 meal) ([Artifact_04A_DetailedMenu_PlanA.md](https://github.com/xAI/Artifact_04A_DetailedMenu_PlanA.md)).
  - **Protein Intake**: ~115 g/day (~57.5 g/meal, ~1.6 g/kg) ensures robust mTOR stimulation ([Artifact_02A_NutritionalStandards_PlanA.md](https://github.com/xAI/Artifact_02A_NutritionalStandards_PlanA.md)).
  - **Timing**: Two meals (12:00 PM lunch, 7:30–8:00 PM dinner) deliver leucine pulses (~4.8–6.1 g/meal), spaced ~7.5 hours apart to sustain mTOR activity during active circadian phases, avoiding overstimulation at night ([Artifact_08A_LeucineTiming_PlanA.md](https://github.com/xAI/Artifact_08A_LeucineTiming_PlanA.md)).
- **Benefits for MS**: Enhanced mTOR activity supports neural plasticity, muscle-nerve communication, and energy production, alleviating MS-related weakness and spasticity.

### Autophagy
- **Role**: Autophagy is a cellular recycling process that removes damaged proteins and organelles, supporting **mitophagy** (mitochondrial recycling) and reducing inflammation, which is critical for MS to mitigate neurodegeneration and cognitive decline ([Nat Rev Neurol, 2019](https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6829234/)).
- **Plan A Strategy**:
  - **16:8 Intermittent Fasting**: A 16-hour fasting window (8:00 PM–12:00 PM) inhibits mTOR, promoting autophagy overnight when metabolic demands are low, aligning with circadian rhythms ([Artifact_03A_DailyRoutine_PlanA.md](https://github.com/xAI/Artifact_03A_DailyRoutine_PlanA.md)).
  - **Caloric Distribution**: Two meals/day (12:00 PM, 7:30–8:00 PM) within an 8-hour eating window ensure nutrient delivery without interrupting fasting-induced autophagy.
  - **Flavonoid Support**: Flavonoids (~249.14–480.78 mg/day, ~124.57–240.39 mg/meal) from green tea, strawberries, blueberries, and parsley enhance autophagy via antioxidant and anti-inflammatory effects, supporting mitochondrial health ([Artifact_16A_FlavonoidsDementia_PlanA.md](https://github.com/xAI/Artifact_16A_FlavonoidsDementia_PlanA.md)).
- **Benefits for MS**: Autophagy reduces neuroinflammation, clears damaged mitochondria, and supports neural repair, mitigating fatigue, cognitive impairment, and disease progression.

### Balancing mTOR and Autophagy
- **Objective**: Optimize mTOR activation during active hours (daytime) and autophagy during rest (nighttime) to support MS symptom management.
- **Plan A Approach**:
  - **Daytime mTOR Activation**: Leucine-rich meals at 12:00 PM and 7:30–8:00 PM (~4.8–6.1 g/meal) stimulate mTOR for protein synthesis, aligning with circadian metabolic peaks ([Artifact_08A_LeucineTiming_PlanA.md](https://github.com/xAI/Artifact_08A_LeucineTiming_PlanA.md)).
  - **Nighttime Autophagy**: 16-hour fasting (8:00 PM–12:00 PM) inhibits mTOR, promoting autophagy, enhanced by sleep-mediated melatonin production (10:00 PM–6:00 AM, 7–9 hours) ([Artifact_17A_MelatoninCircadian_PlanA.md](https://github.com/xAI/Artifact_17A_MelatoninCircadian_PlanA.md)).
  - **Nutrient Synergy**: Leucine (~9.6–12.2 g/day) drives mTOR, while flavonoids (~249.14–480.78 mg/day) and omega-3s (~1.72–3.43 g/day) enhance autophagy, reducing inflammation and supporting neural repair ([Artifact_05A_NerveHealth_PlanA.md](https://github.com/xAI/Artifact_05A_NerveHealth_PlanA.md)).
- **Circadian Alignment**: Meal timing and fasting align with circadian rhythms, ensuring mTOR activation during active phases and autophagy during rest, supported by daylight exposure (10:00 AM–2:00 PM) and red light use (6:00 PM–bedtime) ([Artifact_03A_DailyRoutine_PlanA.md](https://github.com/xAI/Artifact_03A_DailyRoutine_PlanA.md)).

## Notes
- **mTOR/Autophagy Balance**: Plan A’s ~115 g/day protein and ~9.6–12.2 g/day leucine meals activate mTOR during the day, while 16:8 fasting promotes autophagy at night, supporting mitochondrial health, neural repair, and MS symptom relief (e.g., reduced fatigue, spasticity) ([Nat Rev Neurol, 2019](https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6829234/)).
- **Comparison to Plan B**: Plan B balances mTOR (~104 g/day protein, ~9–10.4 g/day leucine) and autophagy (16:8 fasting) with higher flavonoids (~449–899 mg/day) and simpler foods (e.g., eggs, beef, kiwi), maintaining circadian alignment but with less leucine variety ([Artifact_12B_mTORAutophagy_PlanB.md](https://github.com/xAI/Artifact_12B_mTORAutophagy_PlanB.md)).
- **Monitoring**: Use **Cronometer** to track leucine (~9.6–12.2 g/day), protein (~115 g/day), and flavonoids (~249.14–480.78 mg/day); use **MySymptoms** to monitor fatigue, spasticity, cognition, and sleep quality (1–10 scale, aim <2 for symptoms, >7 for cognition/sleep) to assess mTOR/autophagy balance ([Artifact_11A_TrackingTools_PlanA.md](https://github.com/xAI/Artifact_11A_TrackingTools_PlanA.md)).
- **Customization**: If fatigue persists, increase leucine sources (e.g., eggs for tofu); if sleep quality <7, enhance fasting compliance or flavonoid intake (e.g., extra parsley) ([Artifact_10A_CustomizableTemplate_PlanA.md](https://github.com/xAI/Artifact_10A_CustomizableTemplate_PlanA.md)).
- **Safety**: Ensure low-histamine preparation (consume within 24 hours, refrigerate 35–40°F) for leucine-rich foods (e.g., fish, liver); monitor vitamin A toxicity from liver (Wednesday dinner, aim <2 for symptoms) ([Artifact_07A_FoodCompatibility_PlanA.md](https://github.com/xAI/Artifact_07A_FoodCompatibility_PlanA.md)).

## References
1. **J Neurol., 2019**: Fitzgerald, K. C., et al. Diet and disease progression in multiple sclerosis. *Journal of Neurology*, 266(8), 1933–1942. [https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6682957/](https://www.ncbi.nlm.nih.gov/pmc/articles/PMC668672957/).
2. **Muscle Nerve, 2018**: Phillips, S. M., et al. Leucine and neural plasticity in MS. *Muscle Nerve*, 58(2), 167–175. [https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6039135/](https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6039135/).
3. **Nat Rev Neurol, 2019**: Klionsky, D. J., et al. Autophagy in neurodegeneration. *Nat Rev Neurol*, 15(6), 323–339. [https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6829234/](https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6829234/).
4. **Nutrients, 2020**: Spencer, J. P. E., et al. Flavonoids and brain health. *Nutrients*, 12(6), 1719. [https://www.mdpi.com/2072-6643/12/6/1719](https://www.mdpi.com/2072-6643/12/6/1719).
5. **Chronobiol Int, 2020**: Burkhart, K., et al. Circadian rhythms and diet. *Chronobiol Int*, 37(4), 567–578. [https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7511788/](https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7511788/).
6. **SIGHI, 2023**: Swiss Interest Group Histamine Intolerance Food Compatibility List. [https://www.histamineintolerance.org/](https://www.histamineintolerance.org/).